Screened by NARA, 9/13/2023 3. Additional Testing Needed Prior to Approving Medical C' ce No Yes Physical examination or laboratory results contradict medical history Referral prior to departure If yes, provide results False Positive Syphilis Tes/ Referral prior to departure If yes, provide results 4. Follow-up Needed After Arrival No Yes, within 1 week Yes, within 1 month Yes, within 6 months For continuing medication, list type, dose, and frequency For continuing other treatment, specify 5. Remarks (describe any abnormal history, abnormal findings, and resulting interventions) PAPERWORK REDUCTION ACT AND PRIVACY ACT NOTICES Public reporting burden for this collection of information is estimated to average 35 minutes per response, including time required for searching existing data sources, gathering the necessary data, providing the information required, and reviewing the final collection. Persons are not required to provide this information in the absence of a valid OMB approval number. Send comments on the accuracy of this estimate of the burden and recommendations for reducing it to: the U.S. Department of State (A/RPS/DIR) Washington, DC 20520. We ask for information on this form, in the case of applicants for immigrant visas, to determine medical eligibility under INA Sections 212(a) and 221(d), and, in the case of refugees, as required under INA Section 412(b)(4) and (5). If an immigrant visa is issued or refugee status granted, you will convey this form to the Department of Homeland Security (DHS) for disclosure to the Center for Disease Control and the US Public Health Service. Failure to provide this information may delay or prevent the processing of your case. If an immigrant visa is not issued or refugee status is not granted, this form will be treated as confidential under INA Section 222(f). DS-3026 Page 2 of 2